TheraRadar

Pharma Intelligence, Simplified

Landscape Women's Health

Endometriosis

111 clinical trials

29 active
/
111 total (since 2015)
1
Phase 1 Active
24 total
8
Phase 2 Active
49 total
12
Phase 3 Active
32 total
9
Phase 4 Active
16 total

Top Sponsors (Industry)

Sorted by active Active Done Failed
Kissei Pharmaceutical Co., Ltd. 1 3 2
AbbVie 1 1 1
Hope Medicine (Nanjing) Co., Ltd 1 1 0
Gesynta Pharma AB 1 0 0
Changchun GeneScience Pharmaceutical Co., Ltd. 1 0 0
Sumitomo Pharma Switzerland GmbH 1 0 0
Jiangsu Hansoh Pharmaceutical Co., Ltd. 1 0 0
Bio Meds Pharmaceutica Ltda 1 0 0
Hera Biotech, Inc. 1 0 0
Bayer 0 13 3
Jiangsu HengRui Medicine Co., Ltd. 0 3 0
Myovant Sciences GmbH 0 3 0
NCT07015268 ACTIVE NOT RECRUITING
A Clinical Study of KLH-2109 in Patients With Endometriosis
Kissei Pharmaceutical Co., Ltd. n=288
NCT07100782 RECRUITING
Estradiol-mediated Inflammation and Central Sensitization in the Pathophysiology of Endometriosis-associated Pelvic Pain
University of Michigan n=130
NCT04356664 RECRUITING
Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis
Hopital Foch n=180
NCT07318688 NOT YET RECRUITING
Evaluate the Efficacy and Safety of HMI-115 in Women With Moderate to Severe Endometriosis-associated Pain
Hope Medicine (Nanjing) Co., Ltd n=540
NCT05726786 RECRUITING
The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)
Centre Hospitalier Universitaire Vaudois n=232
NCT04333576 ACTIVE NOT RECRUITING
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain
AbbVie n=800
NCT07164183 RECRUITING
Clinical Study to Compare Efficacy and Safety of Indinol Forto® 200 mg Capsules and Visanne 2 mg Tablets in Treatment of Endometriosis
Alcea n=290
NCT05862272 RECRUITING
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Sumitomo Pharma Switzerland GmbH n=1,000
NCT06375811 RECRUITING
Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp
Yale University n=297
NCT06439524 RECRUITING
The Effect of Medical Management Following Excisional Surgery for Endometriosis: A Randomized Controlled Trial
Main Line Health n=110
NCT06161805 RECRUITING
Esketamine as Treatment for Chronic Pain Due to Endometriosis: a RCT Study
Reinier de Graaf Groep n=56
NCT06525155 RECRUITING
Effect GnRH Agonist Administration in Endometriosis Cyst Patients
Rumah Sakit Pusat Angkatan Darat Gatot Soebroto n=32
NCT06076486 COMPLETED
A Clinical Trial to Evaluate Efficacy and Safety of Elagolix Tablets in Women With Moderate or Severe Endometriosis-associated Pain
Nanjing Chia-tai Tianqing Pharmaceutical n=202
NCT04173169 COMPLETED
Pre-IVF Treatment With a GnRH Antagonist in Women With Endometriosis
Yale University n=103
NCT04527003 TERMINATED
Cannabidiol and Management of Endometriosis Pain
Milton S. Hershey Medical Center n=12
NCT03986944 TERMINATED
A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated Pain
Kissei Pharmaceutical Co., Ltd. n=85
NCT03992846 COMPLETED
Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain.
Kissei Pharmaceutical Co., Ltd. n=486
NCT04372121 TERMINATED
Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain
Kissei Pharmaceutical Co., Ltd. n=30
NCT04335591 COMPLETED
Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain (EDELWEISS 6)
Kissei Pharmaceutical Co., Ltd. n=356
NCT05670353 TERMINATED
Cannabidiol for the Treatment of Pelvic Pain in Endometriosis (DREAMLAND)
University of Sao Paulo n=50
NCT03213457 COMPLETED
A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain
AbbVie n=681
NCT06145438 COMPLETED
Comparing the Safety and Efficacy in the Use of Hormonal Therapy on Endometriosis Patients After Conservative Surgery
Universitas Diponegoro n=80
NCT03654274 COMPLETED
SPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated Pain
Myovant Sciences GmbH n=802
NCT03970330 TERMINATED
Low-Dose Naltrexone in Combination With Standard Treatment in Women With Endometriosis
Milton S. Hershey Medical Center n=9
NCT02437175 COMPLETED
Efficacy of Trace Elements in the Treatment of Endometriosis: a Pilot Study
Laboratoires Pronutri n=99
NCT03232281 COMPLETED
Study to Compare the Oestradiol Suppression, Clinical Efficacy and Safety of Two Formulations of Triptorelin (Triptorelin Pamoate PR 3-month and Triptorelin Acetate PR 1-month) in Chinese Subjects With Endometriosis
Ipsen n=300
NCT03204331 COMPLETED
SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain
Myovant Sciences GmbH n=623
NCT03204318 COMPLETED
SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain
Myovant Sciences GmbH n=638
NCT03931915 COMPLETED
Clinical Study to Evaluate Efficacy and Safety of TAK-385 40 mg Compared With Leuprorelin in Patients With Endometriosis
ASKA Pharmaceutical Co., Ltd. n=335
NCT02669238 TERMINATED
Evaluation of a Subcutaneous Progestogen Implants in the Medical Management of Painful Endometriosis
Centre Hospitalier Universitaire de la Réunion n=2
NCT03343067 TERMINATED
A Study to Evaluate Safety and Efficacy of Elagolix in Participants With Endometriosis With Associated Moderate to Severe Pain
AbbVie n=11
NCT02599077 SUSPENDED
Impact vs. Dienogest: A Combined Oral Contraceptive in the Size of Endometriomas
Fundación Santa Fe de Bogota n=50